$207.94
+1.66 (+0.80%)
At Close: Aug 07, 2026
BIIB Class Action Reminder: Contact Robbins LLP for Information About Your Rights Against Biogen Inc.
05:12pm, Friday, 07'th Jun 2024
SAN DIEGO, June 07, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Biogen Inc. (
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Shareholders
01:27pm, Friday, 07'th Jun 2024
NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) of a class action securities lawsuit.
NEW YORK, NY / ACCESSWIRE / June 7, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm Announces it is Investigating Claims Against Biogen Inc. and Encourages Investors with Losses to Contact the Firm.
LOS ANGELES, CA / ACCESSWIRE / June 7, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc. ("Biogen" or "the Com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2024 in Biogen Inc. Lawsuit - BIIB
07:20am, Friday, 07'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 7, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
NEW YORK, NY / ACCESSWIRE / June 7, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit.
Levi & Korsinsky Notifies Shareholders of Biogen Inc. (BIIB) of a Class Action Lawsuit and an Upcoming Deadline
05:15am, Friday, 07'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 7, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
NEW YORK, NY / ACCESSWIRE / June 7, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Biogen Inc. ("Bio
Biogen Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights – BIIB
04:45pm, Thursday, 06'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 6, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biogen Inc.(BIIB) Shareholders
04:45pm, Thursday, 06'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 6, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
RADNOR, PA / ACCESSWIRE / June 6, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States
Class Action Filed Against Biogen Inc. (BIIB) - July 22, 2024 Deadline to Join – Contact The Gross Law Firm
02:42pm, Thursday, 06'th Jun 2024
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Biogen Inc. (NASDAQ: BIIB).
Investors who lost money on Biogen Inc.(BIIB) should contact Levi & Korsinsky about pending Class Action - BIIB
01:00pm, Thursday, 06'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 6, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2024 in Biogen Inc. Lawsuit - BIIB
11:30am, Thursday, 06'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 6, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
Sign In
Buy BIIB